Name | Title | Contact Details |
---|---|---|
Nicholas Campbell |
Chief Commercial Officer | Profile |
Ann Shirriffs |
Human Resources Director | Profile |
Charles-Hubert Devaux |
Senior Director of Patient Recruitment | Profile |
Onicha Cheeranont |
Human Resources Director | Profile |
We offer a wide range of clinical services along with a comprehensive product line. Our professional team is on hand 24/7 to exceed your expectations.
We provide in-home health care for those with illnesses contracted while working in nuclear energy programs.
Black Diamond Therapeutics is a next-wave cancer precision medicine company. Black Diamond pioneered the development of selective medicines for patients with genetically defined cancers driven by oncogenes activated by allosteric mutations. Using its mutation, allostery, and pharmacology (MAP) computational and discovery platform, Black Diamond is uncovering new ways to functionally assess the mutational landscape of individual oncogenes – to discover and validate new targets and develop novel approaches to creating highly selective therapeutics. Black Diamond was founded by David M. Epstein, Ph.D., Elizabeth Buck, Ph.D., and Versant Ventures, and is the first new company to emerge from Versant`s Ridgeline Discovery Engine in Basel, Switzerland.
InnovaSystems is a Pennsauken, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Savage Laboratories is a Melville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.